Related references
Note: Only part of the references are listed.Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
A. Demjaha et al.
PSYCHOLOGICAL MEDICINE (2017)
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review
Amy L. Gillespie et al.
BMC PSYCHIATRY (2017)
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones
Felice Iasevoli et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Profiling cognitive impairment in treatment-resistant schizophrenia patients
Dorota Frydecka et al.
PSYCHIATRY RESEARCH (2016)
Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses
J. Lally et al.
PSYCHOLOGICAL MEDICINE (2016)
Brain metabolite levels and language abilities in preschool children
Catherine Lebel et al.
BRAIN AND BEHAVIOR (2016)
Treatment-Resistant Schizophrenia
Helio Elkis et al.
PSYCHIATRIC CLINICS OF NORTH AMERICA (2016)
Does cognitive impairment in treatment-resistant and ultra-treatment-resistant schizophrenia differ from that in treatment responders?
Valerie M. Anderson et al.
PSYCHIATRY RESEARCH (2015)
Diagnostic change 10 years after a first episode of psychosis
M. Heslin et al.
PSYCHOLOGICAL MEDICINE (2015)
Functional Outcome in People at High Risk for Psychosis Predicted by Thalamic Glutamate Levels and Prefronto-Striatal Activation
Paul Allen et al.
SCHIZOPHRENIA BULLETIN (2015)
1p34.3 Deletion Involving GRIK3: Further Clinical Implication of GRIK Family Glutamate Receptors in the Pathogenesis of Developmental Delay
Toshiki Takenouchi et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2014)
Vocabulary Is an Appropriate Measure of Premorbid Intelligence in a Sample with Heterogeneous Educational Level in Brazil
Maira Okada de Oliveira et al.
BEHAVIOURAL NEUROLOGY (2014)
Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function
Arsime Demjaha et al.
BIOLOGICAL PSYCHIATRY (2014)
Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment
Elsa Gilbert et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2014)
Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study
C. Morgan et al.
PSYCHOLOGICAL MEDICINE (2014)
Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: Correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses
Andrea de Bartolomeis et al.
PSYCHIATRY RESEARCH (2013)
Clozapine and visuospatial processing in treatment-resistant schizophrenia
Josiane Bourque et al.
COGNITIVE NEUROPSYCHIATRY (2013)
Dopamine Synthesis Capacity in Patients With Treatment-Resistant Schizophrenia
Arsime Demjaha et al.
AMERICAN JOURNAL OF PSYCHIATRY (2012)
Cognitive dysfunction and glutamate reuptake: Effect of EAAT2 polymorphism in schizophrenia
Marco Spangaro et al.
NEUROSCIENCE LETTERS (2012)
Linear and non-linear associations of symptom dimensions and cognitive function in first-onset psychosis
Eugenia Kravariti et al.
SCHIZOPHRENIA RESEARCH (2012)
Cognitive and symptomatic predictors of functional disability in schizophrenia
Syed Shamsi et al.
SCHIZOPHRENIA RESEARCH (2011)
Specific and Generalized Neuropsychological Deficits: A Comparison of Patients With Various First-Episode Psychosis Presentations
Jolanta Zanelli et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: Cognitive impairment and clozapine treatment
Yasuhiro Kaneda et al.
PSYCHIATRY RESEARCH (2010)
Selective deficits in semantic verbal fluency in patients with a first affective episode with psychotic symptoms and a positive history of mania
Eugenia Kravariti et al.
BIPOLAR DISORDERS (2009)
Neuropsychological functioning in first-episode schizophrenia
Eugenia Kravariti et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11?
A. Demjaha et al.
PSYCHOLOGICAL MEDICINE (2009)
Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP study
Paul Fearon et al.
PSYCHOLOGICAL MEDICINE (2006)
Comparison of the performance of varimax and promax rotations: Factor structure recovery for dichotomous items
H Finch
JOURNAL OF EDUCATIONAL MEASUREMENT (2006)
Remission in schizophrenia: Proposed criteria and rationale for consensus
NC Andreasen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia
ND Woodward et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: searching for a framework
AH Fanous et al.
MOLECULAR PSYCHIATRY (2005)
Giving meaningful interpretation to ordination axes: Assessing loading significance in principal component analysis
PR Peres-Neto et al.
ECOLOGY (2003)
The National Adult Reading Test as a measure of premorbid intelligence: A comparison with estimates derived from demographic variables
P Bright et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2002)
Neuropsychological impairments in neuroleptic-responder vs. -nonresponder schizophrenic patients and healthy volunteers
R Joober et al.
SCHIZOPHRENIA RESEARCH (2002)
Share Paper
